| References |
|
|
Aartsma-Rus A and
van Ommen GJ
(2007)
Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications.
RNA
13:
1609–1624.
|
|
|
Aartsma-Rus A and
van Ommen GJ
(2010)
Progress in therapeutic antisense applications for neuromuscular disorders.
European Journal of Human Genetics
18:
146–153.
|
|
|
Abes R,
Arzumanov A,
Moulton H et al.
(2008)
Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides.
Journal of Peptide Science
14:
455–460.
|
|
|
Andreadis A
(2006)
Misregulation of tau alternative splicing in neurodegeneration and dementia.
Progress in Molecular and Subcellular Biology
44:
89–107.
|
|
|
Asparuhova MB,
Marti G,
Liu S et al.
(2007)
Inhibition of HIV-1 multiplication by a modified U7 snRNA inducing Tat and Rev exon skipping.
Journal of Gene Medicine
9:
323–334.
|
|
|
Boon KL,
Grainger RJ,
Ehsani P et al.
(2007)
prp8 mutations that cause human retinitis pigmentosa lead to a U5 snRNP maturation defect in yeast.
Nature Structural & Molecular Biology
14:
1077–1083.
|
|
|
Buratti E,
Chivers M,
Kralovicova J et al.
(2007)
Aberrant 5¢ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.
Nucleic Acids Research
35:
4250–4263.
|
|
|
Burghes AH and
Beattie CE
(2009)
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Nature Reviews. Neuroscience
10:
597–609.
|
|
|
Chen M and
Manley JL
(2009)
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.
Nature Reviews. Molecular Cell Biology
10:
741–754.
|
|
|
Cooper TA
(2005)
Use of minigene systems to dissect alternative splicing elements.
Methods
37:
331–340.
|
|
|
Cooper TA and
Mattox W
(1997)
The regulation of splice-site selection, and its role in human disease.
American Journal of Human Genetics
61:
259–266.
|
|
|
Dawson HN,
Cantillana V,
Chen L and
Vitek MP
(2007)
The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
Journal of Neuroscience
27:
9155–9168.
|
|
|
Desmet FO,
Hamroun D,
Lalande M et al.
(2009)
Human splicing finder: an online bioinformatics tool to predict splicing signals.
Nucleic Acids Research
37:
e67.
|
|
|
Divina P,
Kvitkovicova A,
Buratti E and
Vorechovsky I
(2009)
Ab initio prediction of mutation-induced cryptic splice-site activation and exon skipping.
European Journal of Human Genetics
17:
759–765.
|
|
|
Friedman KJ,
Kole J,
Cohn JA et al.
(1999)
Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides.
Journal of Biological Chemistry
274:
36193–36199.
|
|
|
Ghigna C,
Giordano S,
Shen H et al.
(2005)
Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene.
Molecular Cell
20:
881–890.
|
|
|
Hasler J,
Samuelsson T and
Strub K
(2007)
Useful ‘junk’: Alu RNAs in the human transcriptome.
Cellular and Molecular Life Sciences
64:
1793–1800.
|
|
|
Huang HY,
Chien CH,
Jen KH and
Huang HD
(2006)
RegRNA: an integrated web server for identifying regulatory RNA motifs and elements.
Nucleic Acids Research
34:
W429–W434.
|
|
|
Kalbfuss B,
Mabon SA and
Misteli T
(2001)
Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
Journal of Biological Chemistry
276:
42986–42993.
|
|
|
Karni R,
de Stanchina E,
Lowe SW et al.
(2007)
The gene encoding the splicing factor SF2/ASF is a proto-oncogene.
Nature Structural & Molecular Biology
14:
185–193.
|
|
|
Kishore S,
Khanna A and
Stamm S
(2008)
Rapid generation of splicing reporters with pSpliceExpress.
Gene
427:
104–110.
|
|
|
Kishore S,
Khanna A,
Zhang Z et al.
(2010)
The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing.
Human Molecular Genetics
19:
1153–1164.
|
|
|
Kuyumcu-Martinez NM,
Wang GS and
Cooper TA
(2007)
Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.
Molecular Cell
28:
68–78.
|
|
|
Lacerra G,
Sierakowska H,
Carestia C et al.
(2000)
Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients.
Proceedings of the National Academy of Sciences of the USA
97:
9591–9596.
|
|
|
Lebleu B,
Moulton HM,
Abes R et al.
(2008)
Cell penetrating peptide conjugates of steric block oligonucleotides.
Advanced Drug Delivery Reviews
60:
517–529.
|
|
|
Lev-Maor G,
Sorek R,
Shomron N and
Ast G
(2003)
The birth of an alternatively spliced exon: 3¢ splice-site selection in Alu exons.
Science
300:
1288–1291.
|
|
|
Licatalosi DD and
Darnell RB
(2010)
RNA processing and its regulation: global insights into biological networks.
Nature Reviews. Genetics
11:
75–87.
|
|
|
Liu S,
Asparuhova M,
Brondani V et al.
(2004)
Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A.
Nucleic Acids Research
32:
3752–3759.
|
|
|
Lopez-Bigas N,
Audita B,
Ouzounis C,
Parra G and
Guigo R
(2005)
Are splicing mutations the most frequent cause of hereditary disease?
FEBS Letters
579:
1900–1903.
|
|
|
Lunn MR and
Wang CH
(2008)
Spinal muscular atrophy.
Lancet
371:
2120–2133.
|
|
|
Mann CJ,
Honeyman K,
Cheng AJ et al.
(2001)
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse.
Proceedings of the National Academy of Sciences of the USA
98:
42–47.
|
|
|
Meyer K,
Marquis J,
Trub J et al.
(2009)
Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation.
Human Molecular Genetics
18:
546–555.
|
|
|
van Ommen GJ,
van Deutekom J and
Aartsma-Rus A
(2008)
The therapeutic potential of antisense-mediated exon skipping.
Current Opinion in Molecular Therapy
10:
140–149.
|
|
|
Pan Q,
Shai O,
Lee LJ,
Frey BJ and
Blencowe BJ
(2008)
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.
Nature Genetics
40:
1413–1415.
|
|
|
Ranum LP and
Cooper TA
(2006)
RNA-mediated neuromuscular disorders.
Annual Review of Neuroscience
29:
259–277.
|
|
|
Raponi M,
Upadhyaya M and
Baralle D
(2006)
Functional splicing assay shows a pathogenic intronic mutation in neurofibromatosis type 1 (NF1) due to intronic sequence exonization.
Human Mutation
27:
294–295.
|
|
|
Romero PR,
Zaidi S,
Fang YY et al.
(2006)
Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms.
Proceedings of the National Academy of Sciences of the USA
103:
8390–8395.
|
|
|
Sazani P and
Kole R
(2003)
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.
Journal of Clinical Investigation
112:
481–486.
|
|
|
Scaffidi P and
Misteli T
(2005)
Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.
Nature Medicine
11:
440–445.
|
|
|
Schwartz S,
Hall E and
Ast G
(2009)
SROOGLE: webserver for integrative, user-friendly visualization of splicing signals.
Nucleic Acids Research
37:
W189–W192.
|
|
|
Singh NN,
Shishimorova M,
Cao LC,
Gangwani L and
Singh RN
(2009)
A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy.
RNA Biology
6:
341–350.
|
|
|
Singh R N
(2007)
Evolving concepts on human SMN pre-mRNA splicing.
RNA Biology
4:
7–10.
|
|
|
Smith CW and
Valcarcel J
(2000)
Alternative pre-mRNA splicing: the logic of combinatorial control.
Trends in Biochemical Sciences
25:
381–388.
|
|
|
Smith PJ,
Zhang C,
Wang J et al.
(2006)
An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers.
Human Molecular Genetics
15:
2490–2508.
|
|
|
Sorek R,
Ast G and
Graur D
(2002)
Alu-containing exons are alternatively spliced.
Genome Research
12:
1060–1067.
|
|
|
Stamm S,
Ben-Ari S,
Rafalska I et al.
(2005)
Function of alternative splicing.
Gene
344C:
1–20.
|
|
|
Stoilov P,
Lin CH,
Damoiseaux R,
Nikolic J and
Black DL
(2008)
A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators.
Proceedings of the National Academy of Sciences of the USA
105:
11218–11223.
|
|
|
Sumanasekera C,
Watt DS and
Stamm S
(2008)
Substances that can change alternative splice-site selection.
Biochemical Society Transactions
36:
483–490.
|
|
|
book
Tang Y,
Novoyatleva T,
Benderska N et al.
(2005)
"Analysis of alternative splicing in vivo using minigenes".
In: Hartmann RK,
Bindereif A,
Schön A and
Westhof E (eds)
Handbook of RNA Biochemistry,
pp. 755–782.
Weinheim, Germany: Wiley-VCH.
|
|
|
Varon R,
Gooding R,
Steglich C et al.
(2003)
Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome.
Nature Genetics
35:
185–189.
|
|
|
Vithana EN,
Abu-Safieh L,
Allen MJ et al.
(2001)
A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11).
Molecular Cell
8:
375–381.
|
|
|
Vorechovsky I
(2006)
Aberrant 3¢ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.
Nucleic Acids Research
34:
4630–4641.
|
|
|
Watermann DO,
Tang Y,
zur Hausen A et al.
(2006)
Splicing factor Tra2-1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.
Cancer Research
66:
4774–4780.
|
|
|
Wilkie SE,
Vaclavik V,
Wu H et al.
(2008)
Disease mechanism for retinitis pigmentosa (RP11) caused by missense mutations in the splicing factor gene PRPF31.
Molecular Vision
14:
683–690.
|
|
|
Zhang Z,
Lotti F,
Dittmar K et al.
(2008)
SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing.
Cell
133:
585–600.
|
| Further Reading |
|
|
Cooper TA,
Wan L and
Dreyfuss G
(2009)
RNA and disease.
Cell
136:
777–793.
|
|
|
book
Jeanteur P (ed.)
(2006)
Alternative Splicing and Disease, Progress in Molecular and Subcelluar Biology.
Berlin, Heidelberg: Springer.
|
|
|
Tazi J,
Bakkour N and
Stamm S
(2009)
Alternative splicing and disease.
Biochimica Biophysica Acta
1792:
14–26.
|
| Web Links |
|
|
ePath
www.eurasnet.info
|
